(19)

(11)

EP 4 770 667 A1

(12)

(43) Date of publication: 08.07.2026 Bulletin 2026/28 (21) Application number: 24857516.9 (22) Date of filing: 30.08.2024

(51) International Patent Classification (IPC):  A61K 39/00(2006.01) A61K 31/655(2006.01) A61K 39/395(2006.01) A61P 35/04(2006.01) A61K 31/495(2006.01) A61K 31/662(2006.01) A61P 35/00(2006.01) C07K 16/28(2006.01) (52) Cooperative Patent Classification (CPC): A61K 39/00119; A61K 2039/876; A61K 2039/545; A61P 35/00; A61K 31/506; A61K 31/519; A61K 45/06; A61K 39/395; C07K 16/2818; C07K 2317/76   C-Sets: A61K 39/00119, A61K 2300/00; A61K 31/506, A61K 2300/00; A61K 31/519, A61K 2300/00; A61K 39/395, A61K 2300/00; (86) International application number: PCT/AU2024/050927 (87) International publication number: WO 2025/043293 (06.03.2025 Gazette 2025/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 01.09.2023 AU 2023902816 (71) Applicant: Cancuravax Pty Ltd Adelaide, South Australia 5000 (AU)	(72) Inventor: COVENTRY, Brendon, John Adelaide, South Australia 5000 (AU) (74) Representative: Nederlandsch Octrooibureau  P.O. Box 29720 2502 LS The Hague 2502 LS The Hague (NL)